Daedalean wins prize for Artificial Intelligence
Pfäffikon SZ/Zurich - The AiCon event under the patronage of Federal Councilor Guy Parmelin was held for the first time this week. The first national AI award was also presented at the event. The winner is Daedalean, which is developing autonomous piloting systems.
Greenhouse gases turned into sustainable fuel
Zurich – Researchers at the Swiss Federal Institute of Technology in Zurich have developed a catalyst for sustainable synthesis gas. It converts the climate damaging raw materials of carbon dioxide and methane into hydrogen and carbon monoxide. This could potentially help to produce environmentally friendly sustainable fuels and plastics in future.
ZHAW offers online courses worldwide
Winterthur – The Zurich University of Applied Sciences (ZHAW) has put two online courses on the edX online learning platform. It is therefore the first university of applied sciences worldwide to offer this digital campus.
Former Volkswagen CEO joins Piëch Automotive
Zurich – Electric vehicle startup Piëch Automotive is bringing in great expertise with its new appointments. The new Chairman Matthias Müller was previously CEO of Porsche and Volkswagen. The freshly appointed dual CEO leadership team and new Head of Sales offer many years of experience acquired at BMW and Tesla.
Liquity raises seed funding of US$2.4 million
Baar ZG – The crypto startup Liquity has raised seed funding of US $2.4 million. It is building a borrowing protocol for Ethereum that will issue interest-free loans. Liquity now intends to improve access to on-chain borrowing and grow.
ETH spin-offs strengthen the Swiss economy
Zurich – For the third time, the University of St.Gallen has investigated how productive spin-offs from the Swiss Federal Institute of Technology in Zurich (ETH) are. According to the results, these businesses generate far more jobs than the average Swiss start-up. In addition, they are taken over more frequently as well.
COVID-19 drug cuts mortality rate
Molecular Partners has demonstrated the efficacy of its new coronavirus drug in studies conducted with the Free University of Berlin in hamsters. The mortality rate was drastically reduced. In-human trials are set to begin in November.
High-precision drug delivery to brain
Researchers at ETH Zurich have succeeded in developing a high-precision method for delivering therapeutic agents to the brain down to the millimeter. This method should allow psychiatric, neurological and oncological treatments to be undertaken with fewer side effects in future.
Avaloq to become part of NEC
Freienbach SZ – Avaloq is set to change hands. The Japanese IT group NEC is acquiring a 100 percent shareholding in Avaloq. The purchase price for the banking software firm based in the Greater Zurich Area will reach 2.05 billion Swiss francs. Avaloq will continue to operate as an independent entity headquartered in Switzerland.
Meet with an expansion expert
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center? Give us a call or drop us a line.